Bangladesh Journal of Pharmacology https://www.banglajol.info:443/index.php/BJP <p>Bangladesh Journal of Pharmacology (Bangladesh J Pharmacol) is an open access, video component, single blinded peer-reviewed journal of the&nbsp;Bangladesh Pharmacological Society&nbsp;(BDPS). We publish Research article, Mini-review, Meta-analysis, Clinical Trial, Visual Experiment and Letter to the Editor.&nbsp;<br> The author&nbsp;will not be charged in the form of submission fee, article processing fee or publication fee. It is completely free. We do not publish any advertisement.</p> <p><strong>Journal Metrics</strong><br> Journal metrics allow you to compare journals, regardless of their subject classification.<br> Impact Factor&nbsp;(Web of Science) (2018):<strong> 0.811</strong></p> <p><img src="/public/site/images/misbah/impact_factor.png"></p> <p>CiteScore (2018):&nbsp;<strong>0.71</strong>&nbsp;&nbsp;<a href="https://www.scopus.com/sourceid/18200156711">Current month's CiteScore Tracker</a><br> H index (2018): <strong>19</strong></p> <p>We have more than 10,000 readers from South Korea to Nigeria.&nbsp;</p> <p><strong>Abstracted/Indexed in</strong><br>Academic Search Complete, Bangladesh Journals Online, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Current Abstracts,&nbsp;<a href="http://bit.ly/2r4KLsU">Directory of Open Access Journals</a>, EMBASE/Excerpta Medica, Global Health, Google Scholar, HINARI (WHO), International Pharmaceutical Abstracts, Open J-gate,&nbsp;Science Citation Index Expanded, SCOPUS and Social Sciences Citation Index</p> <p><strong>Members</strong><br>Bangladesh Journal of Pharmacology is the member of&nbsp;<a href="https://oaspa.org/member/bangladesh-journal-of-pharmacology/">OASPA</a>&nbsp;(Open Access Scholarly Publishers Association),&nbsp;<a href="http://publicationethics.org/">COPE</a>&nbsp;(Committee on Publication Ethics), The International Society of Managing and Technical Editors (<a href="http://www.ismte.org/members/">ISMTE</a>) and Asian Council of Science Editors.</p> <h1 style="color: red;">Our activities are slow due to COVID-19 Lockdown</h1> en-US <p>Authors who publish with this journal agree to the following terms:</p> <ol> <li class="show">Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a <a href="http://creativecommons.org/licenses/by/4.0/" target="_new"><span style="color: #337755;">Creative Commons Attribution License</span></a> that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.</li> <li class="show">Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.</li> <li class="show">Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See <a href="http://opcit.eprints.org/oacitation-biblio.html" target="_new"><span style="color: #337755;">The Effect of Open Access</span></a>).</li> </ol> dgdabd@gmail.com (Prof. Mir Misbahuddin) banglajol.info@gmail.com (Md Fahmid Uddin Khondoker) Mon, 20 Apr 2020 13:00:44 +0000 OJS 3.1.1.4 http://blogs.law.harvard.edu/tech/rss 60 Effect of capecitabine on breast cancer patients with different estrogen receptor status https://www.banglajol.info:443/index.php/BJP/article/view/43522 <p>This meta-analysis is to compare the efficacy of capecitabine versus non-capecitabine chemotherapy on breast cancer patients with different estrogen receptor (ER) status. We searched relevant literatures from EMBASE, PubMed and OVID library to analyze pathologic complete response rate (PCR), overall survival (OS), disease-free survival (DFS), progression-free survival (PFS), and time to disease progression (TTP). Eleven different studies were enrolled, which revealed that ER positive breast cancer patients who received treatment regimen containing capecitabine can effectively improve PFS, PCR, TTP. However, the difference between capecitabine-containing and non-capecitabine group has no significant for DFS, OS. ER negative breast cancer patients who received treatment regimen containing capecitabine can obviously improve DFS and TTP. However, there was no significant effect for PFS, PCR and OS. The results indicated that capecitabine in combination with other chemotherapy drugs for breast cancer is effective, which can delay the progression time in patients to some extent.</p> Gang Xu, Xin Lv, Ke Lu, Ming Hai Shen, Qing Hua Zhang, Wan Neng Pan ##submission.copyrightStatement## http://creativecommons.org/licenses/by/4.0 https://www.banglajol.info:443/index.php/BJP/article/view/43522 Mon, 20 Apr 2020 12:57:15 +0000 Berberine hydrochloride inhibits inflammatory response via regulating the miRNA-140-5p/TLR4/NF-κB signaling pathway in oral lichen planus https://www.banglajol.info:443/index.php/BJP/article/view/43513 <p>The present study investigates the anti-inflammatory mechanism of berberine hydrochloride in the oral lichen planus. The local inflammatory environment of the oral lichen planus was mimicked, through which lipopolysaccharides stimulated keratinocyte HaCaT cells. Berberine hydrochloride suppressed the activation of the TLR4/NF-κB inflammatory signaling pathway by up-regulating miRNA-140-5p, which is an independent risk factor for the oral lichen planus. Furthermore, miRNA-140-5p inhibited the TLR4/NF-κB inflammatory signaling pathway by directly suppressing TLR4 expression. Therefore, the present study suggests that berberine hydrochloride inhibits the inflammatory response by up-regulating miRNA-140-5p to suppress the activation of the TLR4/NF-κB inflammatory signaling pathway in the oral lichen planus.</p> Qiong Zhang, Liangjun Zhong, Xing Chen, Jintao Wang ##submission.copyrightStatement## http://creativecommons.org/licenses/by/4.0 https://www.banglajol.info:443/index.php/BJP/article/view/43513 Fri, 01 May 2020 06:11:17 +0000 Antimicrobial metabolites from Streptomyces sp. strain PDH23 derived from marine sponge Rhabdastrella globostellata https://www.banglajol.info:443/index.php/BJP/article/view/44526 Vu Thi Thu Huyen, Le Thi Hong Minh, Vu Thi Quyen, Nguyen Mai Anh, Nguyen Thi Kim Cuc, Nguyen Thi Luyen, Nguyen Tien Dat ##submission.copyrightStatement## http://creativecommons.org/licenses/by/4.0 https://www.banglajol.info:443/index.php/BJP/article/view/44526 Mon, 11 May 2020 11:38:33 +0000 Antibacterial activity of Dracaena colorama https://www.banglajol.info:443/index.php/BJP/article/view/45800 Ranjitha Dhevi V. Sundar, Sathiavelu Arunachalam ##submission.copyrightStatement## http://creativecommons.org/licenses/by/4.0 https://www.banglajol.info:443/index.php/BJP/article/view/45800 Sun, 24 May 2020 01:35:18 +0000